Skip to main content
. Author manuscript; available in PMC: 2022 Jan 18.
Published in final edited form as: Mucosal Immunol. 2021 Aug 21;15(1):74–83. doi: 10.1038/s41385-021-00441-3

Figure 3. PTPN2-knockdown macrophages fail to induce IL-4Rα upon treatment with IL-6.

Figure 3.

THP-1 cells expressing non-targeting control (shCtr) or PTPN2-specific (shPTPN2) shRNA were differentiated into macrophages and treated for 24 h (A+D) or the indicated time (B+C) with 20 ng/ml IL-6. Depicted are A) mRNA expression of IL4RA normalized to GAPDH and untreated shCtr cells, B) representative Western blot images for IL-4Rα and β-actin, C) respective densitometry analysis, and D) representative flow cytometry histograms for surface IL-4Ra expression. Gated on life, single cells. ** = p < 0.01 relative to untreated control, ## = p<0.05 relative to IL-6 treated shCtr cells, ANOVA with Dunnett’s multiple comparisons test. Representative results from one out of three independent experiments with n=5 (A+B) or n=3 (C+D) independent replicates.